nodes	percent_of_prediction	percent_of_DWPC	metapath
Estazolam—GABRA3—neck—thyroid cancer	0.0121	0.091	CbGeAlD
Estazolam—GABRR3—head—thyroid cancer	0.00815	0.0613	CbGeAlD
Estazolam—GABRG3—head—thyroid cancer	0.00714	0.0537	CbGeAlD
Estazolam—GABRR2—head—thyroid cancer	0.00707	0.0531	CbGeAlD
Estazolam—GABRP—trachea—thyroid cancer	0.00704	0.053	CbGeAlD
Estazolam—GABRR1—head—thyroid cancer	0.0068	0.0511	CbGeAlD
Estazolam—GABRD—head—thyroid cancer	0.00591	0.0444	CbGeAlD
Estazolam—GABRA3—thyroid gland—thyroid cancer	0.00576	0.0433	CbGeAlD
Estazolam—GABRG1—head—thyroid cancer	0.00569	0.0428	CbGeAlD
Estazolam—GABRB1—head—thyroid cancer	0.00552	0.0415	CbGeAlD
Estazolam—GABRA5—head—thyroid cancer	0.00549	0.0413	CbGeAlD
Estazolam—GABRE—trachea—thyroid cancer	0.00538	0.0404	CbGeAlD
Estazolam—Anxiety—Vandetanib—thyroid cancer	0.0053	0.00612	CcSEcCtD
Estazolam—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00529	0.0061	CcSEcCtD
Estazolam—Hypokinesia—Epirubicin—thyroid cancer	0.00528	0.00609	CcSEcCtD
Estazolam—Dry mouth—Vandetanib—thyroid cancer	0.0052	0.006	CcSEcCtD
Estazolam—Hyperventilation—Epirubicin—thyroid cancer	0.00518	0.00597	CcSEcCtD
Estazolam—GABRA3—head—thyroid cancer	0.00511	0.0384	CbGeAlD
Estazolam—Oedema—Vandetanib—thyroid cancer	0.0051	0.00588	CcSEcCtD
Estazolam—Epistaxis—Sorafenib—thyroid cancer	0.00509	0.00587	CcSEcCtD
Estazolam—Nystagmus—Epirubicin—thyroid cancer	0.00499	0.00575	CcSEcCtD
Estazolam—GABRR2—lymph node—thyroid cancer	0.00495	0.0372	CbGeAlD
Estazolam—Laryngitis—Epirubicin—thyroid cancer	0.00494	0.0057	CcSEcCtD
Estazolam—GABRP—head—thyroid cancer	0.00494	0.0372	CbGeAlD
Estazolam—Hypokinesia—Doxorubicin—thyroid cancer	0.00488	0.00563	CcSEcCtD
Estazolam—Hyperventilation—Doxorubicin—thyroid cancer	0.00479	0.00553	CcSEcCtD
Estazolam—Neuritis—Epirubicin—thyroid cancer	0.00477	0.00551	CcSEcCtD
Estazolam—Scotoma—Epirubicin—thyroid cancer	0.00469	0.00541	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00465	0.00536	CcSEcCtD
Estazolam—Nystagmus—Doxorubicin—thyroid cancer	0.00462	0.00532	CcSEcCtD
Estazolam—Paraesthesia—Vandetanib—thyroid cancer	0.00458	0.00528	CcSEcCtD
Estazolam—Erythema multiforme—Sorafenib—thyroid cancer	0.00458	0.00528	CcSEcCtD
Estazolam—Laryngitis—Doxorubicin—thyroid cancer	0.00458	0.00528	CcSEcCtD
Estazolam—Dyspnoea—Vandetanib—thyroid cancer	0.00455	0.00524	CcSEcCtD
Estazolam—Tinnitus—Sorafenib—thyroid cancer	0.00452	0.00521	CcSEcCtD
Estazolam—Flushing—Sorafenib—thyroid cancer	0.00449	0.00518	CcSEcCtD
Estazolam—Dyspepsia—Vandetanib—thyroid cancer	0.00449	0.00518	CcSEcCtD
Estazolam—Decreased appetite—Vandetanib—thyroid cancer	0.00443	0.00511	CcSEcCtD
Estazolam—Neuritis—Doxorubicin—thyroid cancer	0.00442	0.00509	CcSEcCtD
Estazolam—Pain—Vandetanib—thyroid cancer	0.00436	0.00503	CcSEcCtD
Estazolam—Constipation—Vandetanib—thyroid cancer	0.00436	0.00503	CcSEcCtD
Estazolam—Scotoma—Doxorubicin—thyroid cancer	0.00434	0.00501	CcSEcCtD
Estazolam—Arrhythmia—Sorafenib—thyroid cancer	0.00433	0.00499	CcSEcCtD
Estazolam—GABRE—thyroid gland—thyroid cancer	0.00425	0.032	CbGeAlD
Estazolam—Malnutrition—Sorafenib—thyroid cancer	0.00422	0.00486	CcSEcCtD
Estazolam—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00417	0.00481	CcSEcCtD
Estazolam—GABRG2—head—thyroid cancer	0.00416	0.0313	CbGeAlD
Estazolam—GABRB2—head—thyroid cancer	0.00416	0.0313	CbGeAlD
Estazolam—Muscle spasms—Sorafenib—thyroid cancer	0.00405	0.00467	CcSEcCtD
Estazolam—Body temperature increased—Vandetanib—thyroid cancer	0.00403	0.00465	CcSEcCtD
Estazolam—Abdominal pain—Vandetanib—thyroid cancer	0.00403	0.00465	CcSEcCtD
Estazolam—Thinking abnormal—Epirubicin—thyroid cancer	0.00389	0.00449	CcSEcCtD
Estazolam—Oliguria—Epirubicin—thyroid cancer	0.00387	0.00446	CcSEcCtD
Estazolam—Nocturia—Epirubicin—thyroid cancer	0.00384	0.00443	CcSEcCtD
Estazolam—GABRA2—head—thyroid cancer	0.0038	0.0286	CbGeAlD
Estazolam—Syncope—Sorafenib—thyroid cancer	0.00378	0.00436	CcSEcCtD
Estazolam—Leukopenia—Sorafenib—thyroid cancer	0.00377	0.00435	CcSEcCtD
Estazolam—GABRE—head—thyroid cancer	0.00377	0.0284	CbGeAlD
Estazolam—Ulcer—Epirubicin—thyroid cancer	0.00377	0.00435	CcSEcCtD
Estazolam—Loss of consciousness—Sorafenib—thyroid cancer	0.00371	0.00427	CcSEcCtD
Estazolam—Cough—Sorafenib—thyroid cancer	0.00368	0.00424	CcSEcCtD
Estazolam—GABRA1—head—thyroid cancer	0.00368	0.0276	CbGeAlD
Estazolam—Asthenia—Vandetanib—thyroid cancer	0.00366	0.00422	CcSEcCtD
Estazolam—Coordination abnormal—Epirubicin—thyroid cancer	0.00363	0.00419	CcSEcCtD
Estazolam—Pruritus—Vandetanib—thyroid cancer	0.00361	0.00416	CcSEcCtD
Estazolam—Neck pain—Epirubicin—thyroid cancer	0.00361	0.00416	CcSEcCtD
Estazolam—GABRB3—thyroid gland—thyroid cancer	0.0036	0.0271	CbGeAlD
Estazolam—Thinking abnormal—Doxorubicin—thyroid cancer	0.0036	0.00415	CcSEcCtD
Estazolam—Arthralgia—Sorafenib—thyroid cancer	0.00359	0.00414	CcSEcCtD
Estazolam—Myalgia—Sorafenib—thyroid cancer	0.00359	0.00414	CcSEcCtD
Estazolam—Oliguria—Doxorubicin—thyroid cancer	0.00358	0.00413	CcSEcCtD
Estazolam—Nocturia—Doxorubicin—thyroid cancer	0.00355	0.0041	CcSEcCtD
Estazolam—Dry mouth—Sorafenib—thyroid cancer	0.00351	0.00405	CcSEcCtD
Estazolam—Ulcer—Doxorubicin—thyroid cancer	0.00349	0.00402	CcSEcCtD
Estazolam—Melaena—Epirubicin—thyroid cancer	0.00348	0.00402	CcSEcCtD
Estazolam—Shock—Sorafenib—thyroid cancer	0.00339	0.0039	CcSEcCtD
Estazolam—Dizziness—Vandetanib—thyroid cancer	0.00337	0.00389	CcSEcCtD
Estazolam—Coordination abnormal—Doxorubicin—thyroid cancer	0.00336	0.00387	CcSEcCtD
Estazolam—Neck pain—Doxorubicin—thyroid cancer	0.00334	0.00385	CcSEcCtD
Estazolam—Vomiting—Vandetanib—thyroid cancer	0.00324	0.00374	CcSEcCtD
Estazolam—Melaena—Doxorubicin—thyroid cancer	0.00322	0.00372	CcSEcCtD
Estazolam—Rash—Vandetanib—thyroid cancer	0.00322	0.00371	CcSEcCtD
Estazolam—Dermatitis—Vandetanib—thyroid cancer	0.00321	0.00371	CcSEcCtD
Estazolam—GABRB3—head—thyroid cancer	0.0032	0.024	CbGeAlD
Estazolam—Headache—Vandetanib—thyroid cancer	0.0032	0.00369	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00313	0.00362	CcSEcCtD
Estazolam—Abnormal vision—Epirubicin—thyroid cancer	0.00311	0.00359	CcSEcCtD
Estazolam—Mental disability—Epirubicin—thyroid cancer	0.00309	0.00357	CcSEcCtD
Estazolam—Dyspnoea—Sorafenib—thyroid cancer	0.00307	0.00354	CcSEcCtD
Estazolam—Lymphadenopathy—Epirubicin—thyroid cancer	0.00303	0.0035	CcSEcCtD
Estazolam—Nausea—Vandetanib—thyroid cancer	0.00303	0.00349	CcSEcCtD
Estazolam—Dyspepsia—Sorafenib—thyroid cancer	0.00303	0.00349	CcSEcCtD
Estazolam—Decreased appetite—Sorafenib—thyroid cancer	0.00299	0.00345	CcSEcCtD
Estazolam—Photosensitivity—Epirubicin—thyroid cancer	0.00295	0.0034	CcSEcCtD
Estazolam—Pain—Sorafenib—thyroid cancer	0.00294	0.00339	CcSEcCtD
Estazolam—Constipation—Sorafenib—thyroid cancer	0.00294	0.00339	CcSEcCtD
Estazolam—Vascular purpura—Epirubicin—thyroid cancer	0.00289	0.00334	CcSEcCtD
Estazolam—Abnormal vision—Doxorubicin—thyroid cancer	0.00288	0.00332	CcSEcCtD
Estazolam—Eye pain—Epirubicin—thyroid cancer	0.00287	0.00331	CcSEcCtD
Estazolam—Mental disability—Doxorubicin—thyroid cancer	0.00286	0.0033	CcSEcCtD
Estazolam—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00281	0.00324	CcSEcCtD
Estazolam—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00281	0.00324	CcSEcCtD
Estazolam—Increased appetite—Epirubicin—thyroid cancer	0.00275	0.00318	CcSEcCtD
Estazolam—Urticaria—Sorafenib—thyroid cancer	0.00273	0.00315	CcSEcCtD
Estazolam—Photosensitivity—Doxorubicin—thyroid cancer	0.00273	0.00314	CcSEcCtD
Estazolam—Abdominal pain—Sorafenib—thyroid cancer	0.00272	0.00314	CcSEcCtD
Estazolam—Body temperature increased—Sorafenib—thyroid cancer	0.00272	0.00314	CcSEcCtD
Estazolam—Purpura—Epirubicin—thyroid cancer	0.00268	0.0031	CcSEcCtD
Estazolam—Vascular purpura—Doxorubicin—thyroid cancer	0.00268	0.00309	CcSEcCtD
Estazolam—GABRA2—lymph node—thyroid cancer	0.00266	0.02	CbGeAlD
Estazolam—Eye pain—Doxorubicin—thyroid cancer	0.00265	0.00306	CcSEcCtD
Estazolam—GABRE—lymph node—thyroid cancer	0.00264	0.0199	CbGeAlD
Estazolam—Diplopia—Epirubicin—thyroid cancer	0.00259	0.00298	CcSEcCtD
Estazolam—Pain in extremity—Epirubicin—thyroid cancer	0.00259	0.00298	CcSEcCtD
Estazolam—Increased appetite—Doxorubicin—thyroid cancer	0.00255	0.00294	CcSEcCtD
Estazolam—Affect lability—Epirubicin—thyroid cancer	0.00255	0.00294	CcSEcCtD
Estazolam—Hypersensitivity—Sorafenib—thyroid cancer	0.00253	0.00292	CcSEcCtD
Estazolam—Purpura—Doxorubicin—thyroid cancer	0.00248	0.00286	CcSEcCtD
Estazolam—Asthenia—Sorafenib—thyroid cancer	0.00247	0.00285	CcSEcCtD
Estazolam—Mood swings—Epirubicin—thyroid cancer	0.00245	0.00283	CcSEcCtD
Estazolam—Pruritus—Sorafenib—thyroid cancer	0.00243	0.00281	CcSEcCtD
Estazolam—Ataxia—Epirubicin—thyroid cancer	0.00243	0.00281	CcSEcCtD
Estazolam—Diplopia—Doxorubicin—thyroid cancer	0.00239	0.00276	CcSEcCtD
Estazolam—Pain in extremity—Doxorubicin—thyroid cancer	0.00239	0.00276	CcSEcCtD
Estazolam—Dry skin—Epirubicin—thyroid cancer	0.00237	0.00274	CcSEcCtD
Estazolam—Affect lability—Doxorubicin—thyroid cancer	0.00236	0.00272	CcSEcCtD
Estazolam—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00233	0.00269	CcSEcCtD
Estazolam—Nasopharyngitis—Epirubicin—thyroid cancer	0.00231	0.00267	CcSEcCtD
Estazolam—Gastritis—Epirubicin—thyroid cancer	0.00229	0.00264	CcSEcCtD
Estazolam—Dizziness—Sorafenib—thyroid cancer	0.00228	0.00262	CcSEcCtD
Estazolam—Mood swings—Doxorubicin—thyroid cancer	0.00227	0.00262	CcSEcCtD
Estazolam—Ataxia—Doxorubicin—thyroid cancer	0.00225	0.0026	CcSEcCtD
Estazolam—Asthma—Epirubicin—thyroid cancer	0.00224	0.00258	CcSEcCtD
Estazolam—Dry skin—Doxorubicin—thyroid cancer	0.00219	0.00253	CcSEcCtD
Estazolam—Vomiting—Sorafenib—thyroid cancer	0.00219	0.00252	CcSEcCtD
Estazolam—Rash—Sorafenib—thyroid cancer	0.00217	0.0025	CcSEcCtD
Estazolam—Dermatitis—Sorafenib—thyroid cancer	0.00217	0.0025	CcSEcCtD
Estazolam—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00216	0.00249	CcSEcCtD
Estazolam—Headache—Sorafenib—thyroid cancer	0.00216	0.00249	CcSEcCtD
Estazolam—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00214	0.00247	CcSEcCtD
Estazolam—Gastritis—Doxorubicin—thyroid cancer	0.00212	0.00244	CcSEcCtD
Estazolam—Asthma—Doxorubicin—thyroid cancer	0.00207	0.00239	CcSEcCtD
Estazolam—Pollakiuria—Epirubicin—thyroid cancer	0.00207	0.00238	CcSEcCtD
Estazolam—Nausea—Sorafenib—thyroid cancer	0.00204	0.00236	CcSEcCtD
Estazolam—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00204	0.00235	CcSEcCtD
Estazolam—Weight increased—Epirubicin—thyroid cancer	0.00203	0.00235	CcSEcCtD
Estazolam—Weight decreased—Epirubicin—thyroid cancer	0.00202	0.00233	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00198	0.00228	CcSEcCtD
Estazolam—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00195	0.00225	CcSEcCtD
Estazolam—Sweating—Epirubicin—thyroid cancer	0.00191	0.0022	CcSEcCtD
Estazolam—Pollakiuria—Doxorubicin—thyroid cancer	0.00191	0.0022	CcSEcCtD
Estazolam—Haematuria—Epirubicin—thyroid cancer	0.0019	0.00219	CcSEcCtD
Estazolam—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00189	0.00218	CcSEcCtD
Estazolam—Weight increased—Doxorubicin—thyroid cancer	0.00188	0.00217	CcSEcCtD
Estazolam—Epistaxis—Epirubicin—thyroid cancer	0.00188	0.00217	CcSEcCtD
Estazolam—Weight decreased—Doxorubicin—thyroid cancer	0.00187	0.00216	CcSEcCtD
Estazolam—Sinusitis—Epirubicin—thyroid cancer	0.00187	0.00216	CcSEcCtD
Estazolam—Agranulocytosis—Epirubicin—thyroid cancer	0.00186	0.00215	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00183	0.00211	CcSEcCtD
Estazolam—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00181	0.00209	CcSEcCtD
Estazolam—Rhinitis—Epirubicin—thyroid cancer	0.00179	0.00207	CcSEcCtD
Estazolam—Pharyngitis—Epirubicin—thyroid cancer	0.00178	0.00205	CcSEcCtD
Estazolam—Sweating—Doxorubicin—thyroid cancer	0.00177	0.00204	CcSEcCtD
Estazolam—Haematuria—Doxorubicin—thyroid cancer	0.00176	0.00203	CcSEcCtD
Estazolam—Epistaxis—Doxorubicin—thyroid cancer	0.00174	0.00201	CcSEcCtD
Estazolam—Sinusitis—Doxorubicin—thyroid cancer	0.00173	0.002	CcSEcCtD
Estazolam—Visual impairment—Epirubicin—thyroid cancer	0.00172	0.00199	CcSEcCtD
Estazolam—Agranulocytosis—Doxorubicin—thyroid cancer	0.00172	0.00199	CcSEcCtD
Estazolam—Erythema multiforme—Epirubicin—thyroid cancer	0.00169	0.00195	CcSEcCtD
Estazolam—Tinnitus—Epirubicin—thyroid cancer	0.00167	0.00192	CcSEcCtD
Estazolam—Flushing—Epirubicin—thyroid cancer	0.00166	0.00192	CcSEcCtD
Estazolam—Rhinitis—Doxorubicin—thyroid cancer	0.00166	0.00191	CcSEcCtD
Estazolam—Pharyngitis—Doxorubicin—thyroid cancer	0.00164	0.0019	CcSEcCtD
Estazolam—Chills—Epirubicin—thyroid cancer	0.00161	0.00185	CcSEcCtD
Estazolam—Arrhythmia—Epirubicin—thyroid cancer	0.0016	0.00184	CcSEcCtD
Estazolam—Visual impairment—Doxorubicin—thyroid cancer	0.0016	0.00184	CcSEcCtD
Estazolam—Erythema multiforme—Doxorubicin—thyroid cancer	0.00157	0.00181	CcSEcCtD
Estazolam—Malnutrition—Epirubicin—thyroid cancer	0.00156	0.0018	CcSEcCtD
Estazolam—Tinnitus—Doxorubicin—thyroid cancer	0.00154	0.00178	CcSEcCtD
Estazolam—Flushing—Doxorubicin—thyroid cancer	0.00154	0.00177	CcSEcCtD
Estazolam—Flatulence—Epirubicin—thyroid cancer	0.00154	0.00177	CcSEcCtD
Estazolam—Tension—Epirubicin—thyroid cancer	0.00153	0.00176	CcSEcCtD
Estazolam—Nervousness—Epirubicin—thyroid cancer	0.00151	0.00175	CcSEcCtD
Estazolam—Back pain—Epirubicin—thyroid cancer	0.00151	0.00174	CcSEcCtD
Estazolam—Muscle spasms—Epirubicin—thyroid cancer	0.0015	0.00173	CcSEcCtD
Estazolam—Chills—Doxorubicin—thyroid cancer	0.00149	0.00171	CcSEcCtD
Estazolam—Arrhythmia—Doxorubicin—thyroid cancer	0.00148	0.00171	CcSEcCtD
Estazolam—Ill-defined disorder—Epirubicin—thyroid cancer	0.00145	0.00167	CcSEcCtD
Estazolam—Malnutrition—Doxorubicin—thyroid cancer	0.00144	0.00166	CcSEcCtD
Estazolam—Agitation—Epirubicin—thyroid cancer	0.00143	0.00165	CcSEcCtD
Estazolam—Flatulence—Doxorubicin—thyroid cancer	0.00142	0.00164	CcSEcCtD
Estazolam—Tension—Doxorubicin—thyroid cancer	0.00141	0.00163	CcSEcCtD
Estazolam—Malaise—Epirubicin—thyroid cancer	0.0014	0.00162	CcSEcCtD
Estazolam—Nervousness—Doxorubicin—thyroid cancer	0.0014	0.00161	CcSEcCtD
Estazolam—Syncope—Epirubicin—thyroid cancer	0.0014	0.00161	CcSEcCtD
Estazolam—Leukopenia—Epirubicin—thyroid cancer	0.00139	0.00161	CcSEcCtD
Estazolam—Back pain—Doxorubicin—thyroid cancer	0.00139	0.00161	CcSEcCtD
Estazolam—Muscle spasms—Doxorubicin—thyroid cancer	0.00139	0.0016	CcSEcCtD
Estazolam—Palpitations—Epirubicin—thyroid cancer	0.00138	0.00159	CcSEcCtD
Estazolam—Loss of consciousness—Epirubicin—thyroid cancer	0.00137	0.00158	CcSEcCtD
Estazolam—Cough—Epirubicin—thyroid cancer	0.00136	0.00157	CcSEcCtD
Estazolam—Convulsion—Epirubicin—thyroid cancer	0.00135	0.00156	CcSEcCtD
Estazolam—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00134	0.00154	CcSEcCtD
Estazolam—Arthralgia—Epirubicin—thyroid cancer	0.00133	0.00153	CcSEcCtD
Estazolam—Myalgia—Epirubicin—thyroid cancer	0.00133	0.00153	CcSEcCtD
Estazolam—Chest pain—Epirubicin—thyroid cancer	0.00133	0.00153	CcSEcCtD
Estazolam—Agitation—Doxorubicin—thyroid cancer	0.00132	0.00153	CcSEcCtD
Estazolam—Anxiety—Epirubicin—thyroid cancer	0.00132	0.00152	CcSEcCtD
Estazolam—Discomfort—Epirubicin—thyroid cancer	0.00131	0.00151	CcSEcCtD
Estazolam—Malaise—Doxorubicin—thyroid cancer	0.0013	0.0015	CcSEcCtD
Estazolam—Dry mouth—Epirubicin—thyroid cancer	0.0013	0.0015	CcSEcCtD
Estazolam—Syncope—Doxorubicin—thyroid cancer	0.00129	0.00149	CcSEcCtD
Estazolam—Leukopenia—Doxorubicin—thyroid cancer	0.00129	0.00149	CcSEcCtD
Estazolam—Confusional state—Epirubicin—thyroid cancer	0.00128	0.00148	CcSEcCtD
Estazolam—Palpitations—Doxorubicin—thyroid cancer	0.00127	0.00147	CcSEcCtD
Estazolam—Oedema—Epirubicin—thyroid cancer	0.00127	0.00147	CcSEcCtD
Estazolam—Loss of consciousness—Doxorubicin—thyroid cancer	0.00127	0.00146	CcSEcCtD
Estazolam—Cough—Doxorubicin—thyroid cancer	0.00126	0.00145	CcSEcCtD
Estazolam—Shock—Epirubicin—thyroid cancer	0.00125	0.00144	CcSEcCtD
Estazolam—Convulsion—Doxorubicin—thyroid cancer	0.00125	0.00144	CcSEcCtD
Estazolam—Hyperhidrosis—Epirubicin—thyroid cancer	0.00123	0.00142	CcSEcCtD
Estazolam—Arthralgia—Doxorubicin—thyroid cancer	0.00123	0.00142	CcSEcCtD
Estazolam—Chest pain—Doxorubicin—thyroid cancer	0.00123	0.00142	CcSEcCtD
Estazolam—Myalgia—Doxorubicin—thyroid cancer	0.00123	0.00142	CcSEcCtD
Estazolam—Anxiety—Doxorubicin—thyroid cancer	0.00122	0.00141	CcSEcCtD
Estazolam—Discomfort—Doxorubicin—thyroid cancer	0.00121	0.0014	CcSEcCtD
Estazolam—Dry mouth—Doxorubicin—thyroid cancer	0.0012	0.00138	CcSEcCtD
Estazolam—Confusional state—Doxorubicin—thyroid cancer	0.00119	0.00137	CcSEcCtD
Estazolam—Oedema—Doxorubicin—thyroid cancer	0.00118	0.00136	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00116	0.00134	CcSEcCtD
Estazolam—Shock—Doxorubicin—thyroid cancer	0.00116	0.00134	CcSEcCtD
Estazolam—Paraesthesia—Epirubicin—thyroid cancer	0.00114	0.00132	CcSEcCtD
Estazolam—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00114	0.00131	CcSEcCtD
Estazolam—Dyspnoea—Epirubicin—thyroid cancer	0.00113	0.00131	CcSEcCtD
Estazolam—Somnolence—Epirubicin—thyroid cancer	0.00113	0.0013	CcSEcCtD
Estazolam—Dyspepsia—Epirubicin—thyroid cancer	0.00112	0.00129	CcSEcCtD
Estazolam—Decreased appetite—Epirubicin—thyroid cancer	0.00111	0.00127	CcSEcCtD
Estazolam—Constipation—Epirubicin—thyroid cancer	0.00109	0.00125	CcSEcCtD
Estazolam—Pain—Epirubicin—thyroid cancer	0.00109	0.00125	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00107	0.00124	CcSEcCtD
Estazolam—Paraesthesia—Doxorubicin—thyroid cancer	0.00106	0.00122	CcSEcCtD
Estazolam—Dyspnoea—Doxorubicin—thyroid cancer	0.00105	0.00121	CcSEcCtD
Estazolam—Feeling abnormal—Epirubicin—thyroid cancer	0.00105	0.00121	CcSEcCtD
Estazolam—Somnolence—Doxorubicin—thyroid cancer	0.00105	0.00121	CcSEcCtD
Estazolam—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00104	0.0012	CcSEcCtD
Estazolam—Dyspepsia—Doxorubicin—thyroid cancer	0.00104	0.00119	CcSEcCtD
Estazolam—Decreased appetite—Doxorubicin—thyroid cancer	0.00102	0.00118	CcSEcCtD
Estazolam—Urticaria—Epirubicin—thyroid cancer	0.00101	0.00117	CcSEcCtD
Estazolam—Pain—Doxorubicin—thyroid cancer	0.00101	0.00116	CcSEcCtD
Estazolam—Constipation—Doxorubicin—thyroid cancer	0.00101	0.00116	CcSEcCtD
Estazolam—Body temperature increased—Epirubicin—thyroid cancer	0.00101	0.00116	CcSEcCtD
Estazolam—Abdominal pain—Epirubicin—thyroid cancer	0.00101	0.00116	CcSEcCtD
Estazolam—Feeling abnormal—Doxorubicin—thyroid cancer	0.00097	0.00112	CcSEcCtD
Estazolam—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000962	0.00111	CcSEcCtD
Estazolam—Hypersensitivity—Epirubicin—thyroid cancer	0.000937	0.00108	CcSEcCtD
Estazolam—Urticaria—Doxorubicin—thyroid cancer	0.000935	0.00108	CcSEcCtD
Estazolam—Abdominal pain—Doxorubicin—thyroid cancer	0.00093	0.00107	CcSEcCtD
Estazolam—Body temperature increased—Doxorubicin—thyroid cancer	0.00093	0.00107	CcSEcCtD
Estazolam—Asthenia—Epirubicin—thyroid cancer	0.000912	0.00105	CcSEcCtD
Estazolam—Pruritus—Epirubicin—thyroid cancer	0.0009	0.00104	CcSEcCtD
Estazolam—Hypersensitivity—Doxorubicin—thyroid cancer	0.000867	0.001	CcSEcCtD
Estazolam—Asthenia—Doxorubicin—thyroid cancer	0.000844	0.000974	CcSEcCtD
Estazolam—Dizziness—Epirubicin—thyroid cancer	0.000841	0.00097	CcSEcCtD
Estazolam—Pruritus—Doxorubicin—thyroid cancer	0.000832	0.00096	CcSEcCtD
Estazolam—Vomiting—Epirubicin—thyroid cancer	0.000808	0.000932	CcSEcCtD
Estazolam—Rash—Epirubicin—thyroid cancer	0.000802	0.000925	CcSEcCtD
Estazolam—Dermatitis—Epirubicin—thyroid cancer	0.000801	0.000924	CcSEcCtD
Estazolam—Headache—Epirubicin—thyroid cancer	0.000797	0.000919	CcSEcCtD
Estazolam—Dizziness—Doxorubicin—thyroid cancer	0.000778	0.000897	CcSEcCtD
Estazolam—Nausea—Epirubicin—thyroid cancer	0.000755	0.000871	CcSEcCtD
Estazolam—Vomiting—Doxorubicin—thyroid cancer	0.000748	0.000863	CcSEcCtD
Estazolam—Rash—Doxorubicin—thyroid cancer	0.000742	0.000856	CcSEcCtD
Estazolam—Dermatitis—Doxorubicin—thyroid cancer	0.000741	0.000855	CcSEcCtD
Estazolam—Headache—Doxorubicin—thyroid cancer	0.000737	0.00085	CcSEcCtD
Estazolam—Nausea—Doxorubicin—thyroid cancer	0.000699	0.000806	CcSEcCtD
